Prostate-specific membrane antigen is produced in tumor-associated neovasculature
- PMID: 10537328
Prostate-specific membrane antigen is produced in tumor-associated neovasculature
Abstract
Prostate-specific membrane antigen (PSMA), a type II transmembrane protein, was originally thought to be strictly expressed in prostatic tissue, but recent studies have demonstrated PSMA protein expression in nonprostatic tumor neovasculature as well. Using immunohistochemistry, reverse transcription-PCR assays, and in situ hybridization, we have demonstrated PSMA mRNA transcripts and protein expression in the endothelium of tumor-associated neovasculature of multiple nonprostatic solid malignancies. In addition, we found no PSMA mRNA or protein expression in the vascular endothelial cells of corresponding benign tissue examples. Our findings expand the possible therapeutic role of PSMA and establish it as a unique biomarker specifically produced and expressed by tumor-associated neovasculature but not produced or expressed by normal vessels.
Similar articles
-
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.Cancer Res. 1999 Jul 1;59(13):3192-8. Cancer Res. 1999. PMID: 10397265
-
Prostate-specific membrane antigen expression in normal and malignant human tissues.Clin Cancer Res. 1997 Jan;3(1):81-5. Clin Cancer Res. 1997. PMID: 9815541
-
Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.Int J Cancer. 2003 Nov 1;107(2):323-9. doi: 10.1002/ijc.11402. Int J Cancer. 2003. PMID: 12949815
-
[Detection of PSA mRNA and PSMA mRNA by RT-PCR].Nihon Rinsho. 2002 Dec;60 Suppl 11:151-5. Nihon Rinsho. 2002. PMID: 12599562 Review. Japanese. No abstract available.
-
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases.Urology. 1998 Oct;52(4):637-40. doi: 10.1016/s0090-4295(98)00278-7. Urology. 1998. PMID: 9763084 Review.
Cited by
-
Intra-arterial PSMA injection using hepatic arterial infusion pump in intrahepatic cholangiocarcinoma: a proof-of-concept study.Eur Radiol Exp. 2024 Aug 1;8(1):90. doi: 10.1186/s41747-024-00496-4. Eur Radiol Exp. 2024. PMID: 39090480 Free PMC article.
-
A _targeted low molecular weight near-infrared fluorescent probe for prostate cancer.Bioorg Med Chem Lett. 2010 Dec 1;20(23):7124-6. doi: 10.1016/j.bmcl.2010.09.057. Epub 2010 Sep 17. Bioorg Med Chem Lett. 2010. PMID: 20947349 Free PMC article.
-
An update on PET-based molecular imaging in neuro-oncology: challenges and implementation for a precision medicine approach in cancer care.Quant Imaging Med Surg. 2019 Sep;9(9):1597-1610. doi: 10.21037/qims.2019.08.16. Quant Imaging Med Surg. 2019. PMID: 31667145 Free PMC article. Review.
-
Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer?Curr Urol Rep. 2019 Oct 11;20(11):68. doi: 10.1007/s11934-019-0938-9. Curr Urol Rep. 2019. PMID: 31605269 Review.
-
Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma.Cancers (Basel). 2023 Aug 1;15(15):3922. doi: 10.3390/cancers15153922. Cancers (Basel). 2023. PMID: 37568738 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous